Table 4.

mem-PankoMabGEX ™ staining is an independent prognosticator for advanced 10-year and overall survival

	10-year survival					Overall survival
			95% CI					95% CI
Covariate	Coefficient (b i )	[HR Exp (b i )]	Lower	Upper	P-value	Coefficient (b i )	[HR Exp (b i )]	Lower	Upper	P-value
Histology (NST vs. other)	−0.49	0.61	0.16	2.38	ns	−0.31	0.73	0.23	2.34	ns
Grading (G1. G2 vs. G3)	−0.51	0.60	0.18	1.97	ns	−0.59	0.55	0.19	1.63	ns
pT (pT1 vs. pT2-pT4)	−0.17	0.84	0.30	2.36	ns	−0.06	0.94	0.39	2.26	ns
pN (pN0 vs. pN1-pN3)	0.61	1.84	0.63	5.40	ns	1.06	2.89	1.11	7.53	.030
CIS (fraction within the invasive carcinoma) (no vs. yes)	0.08	1.08	0.40	2.97	ns	0.28	1.32	0.57	3.06	ns
ER (neg. vs. pos.)	−1.53	0.22	0.05	0.94	.041	−1.66	0.19	0.05	0.80	.023
PR (neg. vs. pos.)	0.10	1.10	0.28	4.28	ns	0.37	1.45	0.43	4.91	ns
Her2 (neg. vs. pos.)	0.92	2.52	0.56	11.35	ns	0.67	1.95	0.46	8.20	ns
age (≤55y vs. > 55 y.)	0.75	2.11	0.71	6.30	ns	0.28	1.32	0.55	3.18	ns
mem-PankoMabGEX™ (neg. vs. pos.)	−2.42	0.09	0.01	0.70	.022	−1.21	0.30	0.09	0.96	.042